Trial Profile
A Pilot, Phase-I Trial of Rabbit Anti-Thymocyte Globulin (rATG, Thymoglobulin) in Combination With Rapamycin in Relapsed Multiple Myeloma (MM).
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Antithymocyte globulin (Primary) ; Sirolimus (Primary)
- Indications Multiple myeloma
- Focus Adverse reactions
- 29 Aug 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 29 Aug 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 23 Nov 2006 New trial record.